Paking, Insahaya .
HRN: 26-61-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
02/03/2025
02/09/2025
IV
750 Mg
Q8
For 7 Days
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes